Belfort M, Uys P, Dommisse J, Davey D A
Department of Obstetrics and Gynaecology, University of Cape Town Medical School, Observatory, South Africa.
Br J Obstet Gynaecol. 1989 Jun;96(6):634-41. doi: 10.1111/j.1471-0528.1989.tb03276.x.
Ten patients with gestational proteinuric hypertension were studied with a Swan-Ganz thermodilution haemodynamic catheter before, during and after plasma volume expansion. Five patients were treated with dihydralazine before volume expansion and five after volume expansion. Before treatment all patients had a low pulmonary capillary wedge pressure (PCWP), low cardiac index (CI) and high systemic vascular resistance (SVR). Following volume expansion the PCWP and CI increased, the SVR decreased but the blood pressure (BP) was unchanged. Administration of dihydralazine following volume expansion led to a decrease in PCWP, an increase in CI and a decrease in SVR and BP. Dihydralazine alone caused an increase in heart rate, PCWP, and CI, and a decrease in SVR and BP. Volume expansion, by increasing CI and decreasing SVR, may be of therapeutic benefit in the severely hypertensive pregnant patient with a low cardiac index.
对10例妊娠蛋白尿性高血压患者在血浆容量扩充前、扩充期间及扩充后使用Swan-Ganz热稀释血流动力学导管进行研究。5例患者在容量扩充前接受双肼屈嗪治疗,5例在容量扩充后接受双肼屈嗪治疗。治疗前,所有患者的肺毛细血管楔压(PCWP)较低、心脏指数(CI)较低且全身血管阻力(SVR)较高。容量扩充后,PCWP和CI升高,SVR降低,但血压(BP)未改变。容量扩充后给予双肼屈嗪导致PCWP降低、CI升高、SVR和BP降低。单独使用双肼屈嗪会导致心率、PCWP和CI升高,SVR和BP降低。通过增加CI和降低SVR进行容量扩充,可能对心脏指数较低的重度高血压孕妇具有治疗益处。